Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gloria L Vega

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|October 31, 2021
Statin Intolerance and Noncompliance: An Empiric ApproachScott M Grundy, Gloria L Vega
Journal of Clinical Lipidology|February 5, 2011
Counterpoint: Lipoproteins and dementia: Is there compelling evidence to treat Alzheimer's patients with statins?Peter W F Wilson, Gloria L Vega
Journal of Clinical Lipidology|February 5, 2011
Closing commentPeter W F Wilson, Gloria L Vega
Journal of Clinical Lipidology|January 2, 2023
Statin therapy for primary prevention in men: What is the role for coronary artery calcium?Scott M Grundy, Jijia Wang, Gloria L Vega
Journal of Clinical Lipidology|December 19, 2021
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic diseaseGloria L Vega, Jijia Wang, Scott M Grundy
European Journal of Clinical Investigation|April 24, 2018
Upper body fat predicts metabolic syndrome similarly in men and womenScott M Grundy, Corbin Williams, Gloria L Vega
The American Journal of Cardiology|January 6, 2023
Is There a Role for Coronary Calcium in Patients With Diabetes?Scott M Grundy, Gloria L Vega, Nathan D Wong
Journal of the Academy of Nutrition and Dietetics|June 19, 2017
Orthorexia Nervosa and Eating Disorder Symptoms in Registered Dietitian Nutritionists in the United StatesKaylee Tremelling, Lona Sandon, Gloria L Vega, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
Ethnic differences in hepatic steatosis: an insulin resistance paradox?Richard Guerrero, Gloria L Vega, Scott M Grundy, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 9, 2016
Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathyAnand Srivastava, Beverley Adams-Huet, Gloria L Vega, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|October 31, 2021
Statin Intolerance and Noncompliance: An Empiric ApproachScott M Grundy, Gloria L Vega
Journal of Clinical Lipidology|February 5, 2011
Counterpoint: Lipoproteins and dementia: Is there compelling evidence to treat Alzheimer's patients with statins?Peter W F Wilson, Gloria L Vega
Journal of Clinical Lipidology|February 5, 2011
Closing commentPeter W F Wilson, Gloria L Vega
Journal of Clinical Lipidology|January 2, 2023
Statin therapy for primary prevention in men: What is the role for coronary artery calcium?Scott M Grundy, Jijia Wang, Gloria L Vega
Journal of Clinical Lipidology|December 19, 2021
Prevalence and significance of risk enhancing biomarkers in the United States population at intermediate risk for atherosclerotic diseaseGloria L Vega, Jijia Wang, Scott M Grundy
European Journal of Clinical Investigation|April 24, 2018
Upper body fat predicts metabolic syndrome similarly in men and womenScott M Grundy, Corbin Williams, Gloria L Vega
The American Journal of Cardiology|January 6, 2023
Is There a Role for Coronary Calcium in Patients With Diabetes?Scott M Grundy, Gloria L Vega, Nathan D Wong
Journal of the Academy of Nutrition and Dietetics|June 19, 2017
Orthorexia Nervosa and Eating Disorder Symptoms in Registered Dietitian Nutritionists in the United StatesKaylee Tremelling, Lona Sandon, Gloria L Vega, et al.
Hepatology (Baltimore, Md.)|December 24, 2008
Ethnic differences in hepatic steatosis: an insulin resistance paradox?Richard Guerrero, Gloria L Vega, Scott M Grundy, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|July 9, 2016
Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathyAnand Srivastava, Beverley Adams-Huet, Gloria L Vega, et al.
Pageof 5